SIREN : 444325112
BIOPRAXIA is a French company founded 23 years ago, specialized in the sector Enseignement supérieur. Based in RENNES (35000), this company of category PME shows in 2020 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 1 984 381 € | N/C | N/C | 1 235 962 € |
| Net income | 574 326 € | 486 906 € | 439 558 € | 415 821 € | 362 463 € | 243 161 € | 321 598 € | 174 116 € | 108 851 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | 351 288 € | N/C | N/C | 170 575 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | 12.3% | N/C | N/C | 8.8% |
In 2025, BIOPRAXIA generates positive net income of 574 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 109 k€ -> 574 k€.
574 326 €
The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
41.848%
54.674%
40.2%
In 2025, the debt ratio of BIOPRAXIA (41.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of BIOPRAXIA (54.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 272.24. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
272.239
In 2025, the liquidity ratio of BIOPRAXIA (272.24) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 412 transactions of similar company sales (all years), the value of BIOPRAXIA is estimated at 2 202 014 € (range 853 713€ - 8 179 689€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 412 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOPRAXIA with other companies in the same sector:
Voir toutes les statistiques du secteur Enseignement supérieur
The revenue of BIOPRAXIA in 2020 is 2.0 M€.
Yes, BIOPRAXIA generated a net profit of 574 k€ in 2025.
The headquarters of BIOPRAXIA is located in RENNES (35000), in the department Ille-et-Vilaine.
The tax return of BIOPRAXIA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOPRAXIA operates in the sector Enseignement supérieur (NAF code 85.42Z). See the 'Sector positioning' section above to compare the company with its competitors.